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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of a health claim related to coffee 
C21, a coffee standardised by its content of caffeoylquinic acids, 
trigonelline and N-methylpyridinium, and reduction of DNA damage by 
decreasing spontaneous DNA strand breaks pursuant to Article 13(5) of 
Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following an application from Tchibo GmbH, submitted for authorisation of a health claim pursuant to 
Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on 
Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation 
of a health claim related to coffee C21 and reduction of DNA damage by decreasing spontaneous DNA strand 
breaks. The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence. Coffee C21, a coffee standardised by its content of caffeoylquinic acids, trigonelline and 
N-methylpyridinium (NMP), which is the subject of the health claim, is sufficiently characterised. Reduction of 
DNA damage by decreasing spontaneous DNA strand breaks is a beneficial physiological effect. In weighing the 
evidence, the Panel took into account that one human intervention study showed that daily consumption of coffee 
C21 (750 ml/day) for four weeks decreased spontaneous DNA strand breaks in habitual coffee drinkers after 
coffee withdrawal over the previous four weeks, but that no other human studies in which these results have been 
replicated were provided, and that no evidence was provided for a mechanism by which coffee (including coffee 
C21) could exert the claimed effect. The Panel concludes that a cause and effect relationship has not been 
established between the consumption of coffee C21, a coffee standardised by its content of caffeoylquinic acids, 
trigonelline and NMP, and a reduction of DNA damage by decreasing spontaneous DNA strand breaks. 
© European Food Safety Authority, 2015 
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SUMMARY 
Following an application from Tchibo GmbH, submitted for authorisation of a health claim pursuant 
to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on 
the scientific substantiation of a health claim related to coffee C21, a coffee standardised by its 
content of caffeoylquinic acids, trigonelline and N-methylpyridinium (NMP), and reduction of DNA 
damage by decreasing spontaneous DNA strand breaks. 
The scope of the application was proposed to fall under a health claim based on newly developed 
scientific evidence.  
The food that is the subject of the health claim is coffee C21. Coffee C21 is a blend of roasted coffee 
arabica (Coffea arabica L.) standardised by its content of caffeoylquinic acids, trigonelline and NMP. 
Caffeoylquinic acids, trigonelline and NMP can be measured in ground and brewed coffee by 
established methods. The Panel considers that the food, coffee C21, a coffee standardised by its 
content of caffeoylquinic acids, trigonelline and NMP, is sufficiently characterised. 
The claimed effect proposed by the applicant is ‘reduction of the amount of spontaneous DNA strand 
breaks in white blood cells’. The target population proposed by the applicant is the general 
population. Spontaneous DNA strand breaks normally occur during the DNA repair process. DNA 
strand break, which may also be induced by genetic or environmental factors, is a type of DNA 
damage which can be measured by the comet assay (single-cell gel electrophoresis). The Panel 
considers that the reduction of DNA damage by decreasing spontaneous DNA strand breaks is a 
beneficial physiological effect. 
The applicant identified six human intervention studies as being pertinent to the health claim. 
These studies (except for one) were carried out with coffee types which did not comply with the 
specifications of coffee C21, which is standardised by its content of caffeoylquinic acids, trigonelline 
and NMP, were uncontrolled or did not report on spontaneous DNA strand breaks. The Panel 
considers that no conclusions can be drawn from these five studies for the scientific substantiation of 
the claim. 
One placebo-controlled, randomised, single-blind, parallel study investigated the effect of consuming 
coffee C21 on spontaneous DNA strand breaks in healthy non-smoking males, who were accustomed 
to a daily coffee consumption level similar to that being investigated in this study. A total of 90 
subjects were randomised (stratified by body mass index) in two groups. In the first four-week run-in 
period, all participants refrained from consuming coffee and instead consumed water. During the 
following four weeks participants consumed either coffee C21 (n=45; 45 g coffee/750 ml per day) or 
the same volume of water (n=45). The investigator was unaware of the treatment group allocation.  
Difference in spontaneous DNA strand break changes in peripheral white blood cells between groups 
was the primary outcome of this study. 
At baseline (i.e. after the run-in period), there was no difference in spontaneous DNA strand breaks 
between the groups. During the four-week intervention period spontaneous DNA strand breaks 
decreased in the intervention group and increased in the control group. 
The Panel considers that this study shows that daily consumption of coffee C21 (750 ml/day) for four 
weeks decreases spontaneous DNA strand breaks in habitual coffee drinkers after coffee withdrawal 
over the previous four weeks.  
The applicant provided two animal and two in vitro studies in support of a mechanism by which 
coffee C21 could exert the claimed effect. The Panel considers that these studies do not provide 
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evidence for a mechanism by which coffee C21 could reduce DNA damage by decreasing 
spontaneous DNA strand breaks.  
In weighing the evidence, the Panel took into account that one human intervention study showed that 
daily consumption of coffee C21 (750 ml/day) for four weeks decreased spontaneous DNA strand 
breaks in habitual coffee drinkers after coffee withdrawal over the previous four weeks, but that no 
other human studies in which these results have been replicated were provided, and that no evidence 
was provided for a mechanism by which coffee (including coffee C21) could exert the claimed effect.  
The Panel concludes that a cause and effect relationship has not been established between the 
consumption of coffee C21, a coffee standardised by its content of caffeoylquinic acids, trigonelline 
and NMP, and a reduction of DNA damage by decreasing spontaneous DNA strand breaks. 
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BACKGROUND 
Regulation (EC) No 1924/2006
4
 harmonises the provisions that relate to nutrition and health claims, 
and establishes rules governing the Community authorisation of health claims made on foods. As a 
rule, health claims are prohibited unless they comply with the general and specific requirements of 
this Regulation, are authorised in accordance with this Regulation, and are included in the lists of 
authorised claims provided for in Articles 13 and 14 thereof. In particular, Article 13(5) of this 
Regulation lays down provisions for the addition of claims (other than those referring to the reduction 
of disease risk and to children’s development and health) which are based on newly developed 
scientific evidence, or which include a request for the protection of proprietary data, to the 
Community list of permitted claims referred to in Article 13(3). 
According to Article 18 of this Regulation, an application for inclusion in the Community list of 
permitted claims referred to in Article 13(3) shall be submitted by the applicant to the national 
competent authority of a Member State, which will make the application and any supplementary 
information supplied by the applicant available to the European Food Safety Authority (EFSA). 
STEPS TAKEN BY EFSA 
 The application was received on 12/09/2014. 
 The scope of the application was proposed to fall under a health claim based on newly 
developed scientific evidence. 
 On 20/10/2014, during the validation process of the application, EFSA sent a request to the 
applicant to provide missing information. 
 On 30/10/2014, EFSA received the missing information as submitted by the applicant. 
 The scientific evaluation procedure started on 06/11/2014. 
 On 26/11/2014, the Working Group on Claims of the NDA Panel agreed on a list of questions 
for the applicant to provide additional information to accompany the application. The clock 
was stopped on 05/12/2014 in compliance with Article 18(3) of Regulation (EC) 
No 1924/2006. 
 On 19/12/2014, EFSA received the applicant’s reply and the clock was re-started. 
 During its meeting on 22/04/2015, the NDA Panel, having evaluated the data submitted, 
adopted an opinion on the scientific substantiation of a health claim related to coffee C21, a 
coffee standardised by its content of caffeoylquinic acids, trigonelline and 
N-methylpyridinium, and reduction of DNA damage by decreasing spontaneous DNA strand 
breaks.  
TERMS OF REFERENCE 
EFSA is requested to evaluate the scientific data submitted by the applicant in accordance with 
Article 16(3) of Regulation (EC) No 1924/2006. On the basis of that evaluation, EFSA will issue an 
opinion on the scientific substantiation of a health claim related to: coffee C21, a coffee standardised 
by its content of caffeoylquinic acids, trigonelline and N-methylpyridinium, and reduction of DNA 
damage by decreasing spontaneous DNA strand breaks. 
                                                     
4 Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25. 
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EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation for the 
marketing of coffee C21, a positive assessment of its safety, nor a decision on whether coffee C21 is, 
or is not, classified as a foodstuff. It should be noted that such an assessment is not foreseen in the 
framework of Regulation (EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wording of the claim, and the conditions of 
use as proposed by the applicant may be subject to changes, pending the outcome of the authorisation 
procedure foreseen in Article 18(4) of Regulation (EC) No 1924/2006. 
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INFORMATION PROVIDED BY THE APPLICANT 
Applicant’s name and address 
Tchibo GmbH, Überseering 18, D-22297 Hamburg, Germany. 
Food/constituent as stated by the applicant 
According to the applicant, the food for which the claim is made is coffee C21, a special blend of 
roasted pure arabica coffee (Coffea arabica L.) without any non-coffee ingredients, which is 
standardised by its content of caffeoylquinic acids (chlorogenic acids), N-methylpyridinium and 
trigonelline. 
Health relationship as claimed by the applicant 
According to the applicant, consumption of coffee C21 leads to a reduction of the amount of 
spontaneous DNA strand breaks in white blood cells, which are measured by the comet assay. 
Wording of the health claim as proposed by the applicant 
The applicant has proposed the following wording for the health claim: ‘Regular consumption of 
coffee C21 contributes to the maintenance of DNA integrity in cells of the body’. 
Specific conditions of use as proposed by the applicant 
The target population proposed by the applicant is the general population.  
The conditions of use proposed by the applicant are three large cups of coffee C21 (each 250 ml, 
prepared from two pads of 7.5 g ground coffee) per day. 
ASSESSMENT 
1. Characterisation of the food/constituent  
The food that is the subject of the health claim is coffee C21.  
Brewed coffee is a mixture of compounds, including coffee constituents, such as caffeine, 
caffeoylquinic acids and trigonelline, together with compounds formed during roasting, such as 
N-methylpyridinium (NMP), nicotinic acid, nicotinamide and melanoidins (Lang et al., 2008). 
Coffee C21 is a blend of roasted coffee arabica (Coffea arabica L.). The roasting is accomplished 
with regular coffee manufacturing roasters which apply heat to dry beans. Roasted ground coffee 
(coffee C21) is standardised by its concentrations of chlorogenic acids (also called caffeoylquinic 
acids, polyphenols), trigonelline (alkaloid) and NMP (pyridine derivative). The concentrations of 
chlorogenic acids, trigonelline and the thermal degradation product NMP depend on the degree of 
roasting. The desired composition is obtained by blending different coffee roasts and by adjusting the 
roasting conditions (temperature and time). A decline of 6.6 % in caffeoylquinic acids was reported 
during 45 months of storage at room temperature.  
The applicant indicated that ground coffee C21 contains 10.18 mg/g of caffeoylquinic acids, 
3.82 mg/g of trigonelline and 1.10 mg/g of NMP. Upon a request by EFSA for clarification of the 
standardisation of coffee C21, the applicant indicated the minimum amount of caffeoylquinic acids, 
trigonelline and NMP in ground coffee C21 (9.16 mg/g, 3.44 mg/g and 0.99 mg/g, respectively). 
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According to the applicant, coffee C21 is prepared with a standard drip filter coffee machine, using a 
20:1 (w/w) ratio of tap water to ground coffee, which results in a > 90 % extraction of caffeoylquinic 
acids, trigonelline and NMP.  
Caffeoylquinic acids, trigonelline and NMP can be measured in ground and brewed coffee by 
established methods. 
The Panel considers that the food, coffee C21, a coffee standardised by its content of caffeoylquinic 
acids, trigonelline and NMP, which is the subject of the health claim, is sufficiently characterised. 
2. Relevance of the claimed effect to human health 
The claimed effect proposed by the applicant is ‘reduction of the amount of spontaneous DNA strand 
breaks in white blood cells’. The target population proposed by the applicant is the general 
population. 
Spontaneous DNA strand breaks normally occur during the DNA repair process. DNA strand breaks 
may also be induced by genetic or environmental factors (e.g. mutagenic or pro-oxidant chemicals and 
radiation). Such DNA strand breaks alter DNA properties, may induce anomalies during DNA 
replication and translation, and require repair for the maintenance of cell functioning and survival. 
A DNA strand break is a type of DNA damage which can be measured by the comet assay (single-cell 
gel electrophoresis) (EFSA NDA Panel, 2011).  
The Panel considers that the reduction of DNA damage by decreasing spontaneous DNA strand 
breaks is a beneficial physiological effect. 
3. Scientific substantiation of the claimed effect 
The applicant performed a literature search in PubMed with the following terms: ‘coffee and DNA 
damage’, ‘coffee and DNA strand break(s)’, ‘coffee and Comet assay’, ‘caffeine and DNA damage 
and trial’, ‘chlorogenic acid and DNA damage and trial’, ‘trigonelline and DNA damage and trial’, 
‘methyl pyridinium and DNA damage and trial’ and ‘niacin and DNA damage and trial’. 
The applicant identified six human intervention studies as being pertinent to the health claim. 
These studies (except for one) were carried out with coffee types which did not comply with the 
specifications of coffee C21, which is standardised by its content of caffeoylquinic acids, trigonelline 
and NMP (Steinkellner et al., 2005; Bichler et al., 2007; Hoelzl et al., 2010; Misik et al., 2010), were 
uncontrolled (Steinkellner et al., 2005; Bichler et al., 2007; Bakuradze et al., 2011) or did not report 
on spontaneous DNA strand breaks (Steinkellner et al., 2005; Hoelzl et al., 2010). The Panel 
considers that no conclusions can be drawn from these five studies for the scientific substantiation of 
the claim. 
The placebo-controlled, randomised, single-blind, parallel study by Bakuradze et al. (2015) 
investigated the effect of consuming coffee C21 on spontaneous DNA strand breaks in healthy 
non-smoking males (aged 19-50 years; body mass index (BMI) 19-32 kg/m
2
), who were accustomed 
to a daily coffee consumption level similar to that being investigated in this study (i.e. 45 g/750 ml). A 
total of 90 subjects were randomised (stratified by BMI) in two groups. In the first four-week run-in 
period, all participants refrained from consuming coffee and instead consumed water (750 ml). During 
the following four weeks participants consumed either coffee C21 (n=45; 45 g coffee/750 ml per day) 
or the same volume of water (n=45). Upon a request by EFSA for clarification of the caffeine 
consumption, the applicant indicated that the consumption of coffee C21 led to a daily ingestion of 
531 mg of caffeine in the intervention group. The investigator was unaware of the treatment group 
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allocation. During the run-in and the intervention periods participants were instructed to consume 
their usual diet and to avoid consuming coffee and caffeine-containing products and foods rich in 
polyphenols. Participants recorded their food intake in the final seven days of each study period. At 
the end of the run-in and intervention periods blood samples were taken for determination of 
spontaneous DNA strand breaks through the comet assay. At those visits urine samples and body 
weight measurements were also taken.  
Difference in spontaneous DNA strand break changes in peripheral white blood cells between groups 
was the primary outcome of this study. The sample size (target significance level α = 5 %, at a power 
of 80 %) was calculated based on a previous human intervention study, which also used the comet 
assay (Bakuradze et al., 2011).  
Six participants withdrew from the study (n=3 in each group) owing to ‘private’ reasons. Compliance 
was assessed by monitoring trigonelline and NMP in urine. Upon a request by EFSA for clarification, 
the applicant indicated that these six participants were not included in the statistical analyses as they 
withdrew from the study in the run-in period (i.e. before the collection of baseline values).  
Daily energy and macronutrient intake during the run-in and the intervention periods were not 
different between the groups. No changes in body weight were observed between the groups during 
the whole study period. 
An analysis of covariance (ANCOVA) test, with baseline data as covariate, was used to assess the 
difference in spontaneous DNA strand break changes between groups. Additionally, the Wilcoxon 
rank sum test was used to cross-check the ANCOVA results.  
The results of comet assays were presented as means, with standard deviations, of spontaneous DNA 
strand breaks, expressed as tail intensities (TI %). At baseline (i.e. after the run-in period), there was 
no difference in the mean of spontaneous DNA strand breaks between the groups. During the 
four-week intervention period the mean of spontaneous DNA strand breaks decreased in the 
intervention group and increased in the control group (from 0.32±0.11 to 0.27±0.09 TI % in the 
intervention group and from 0.31±0.12 to 0.37±0.15 TI % in the control group; ANCOVA, 
p = 0.0002; Wilcoxon rank sum test, p = 0.0005).  
The Panel considers that this study shows that daily consumption of coffee C21 (750 ml/day) for four 
weeks decreases spontaneous DNA strand breaks in habitual coffee drinkers after coffee withdrawal 
over the previous four weeks.  
Mechanism by which the food could exert the claimed effect 
The applicant indicated that the effect of coffee C21 on the decrease of spontaneous DNA strand 
breaks was mainly exerted by NMP, the major alkylpyridinium compound in roasted coffee. 
According to the applicant, NMP would protect against the formation of DNA strand breaks by 
inducing the activity of enzymes involved in the cellular defence against oxidative damage and ‘other 
stress’ by inducing the nuclear translocation of the transcription factor nuclear-factor-E2-related 
factor 2 (Nrf2) and thereby regulating antioxidant response element (ARE)/electrophile response 
element (EpRE) pathways.  
The applicant provided two animal (Paur et al., 2010; Vicente et al., 2014) and two in vitro studies 
(Bakuradze et al., 2010; Boettler et al., 2011) in support of a mechanism by which coffee C21 could 
exert the claimed effect. 
These studies investigated the effect of different coffee brews/extracts (different from coffee C21) on 
cytosolic and nuclear concentrations of Nrf2, and on the expression and activity of 
ARE/EpRE-dependent enzymes. The results on the effect of NMP on the expression of ARE-
dependent enzymes in the two in vitro studies were inconsistent.  The Panel notes that none of the 
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studies provided addressed whether the proposed changes in cytosolic and nuclear concentrations of 
Nrf2, or the expression and activity of ARE/EpRE-dependent enzymes, would affect DNA strand 
breaks.  
The Panel considers that the animal and in vitro studies do not provide evidence for a mechanism by 
which coffee C21 could reduce DNA damage by decreasing spontaneous DNA strand breaks.  
Weighing the evidence 
In weighing the evidence, the Panel took into account that one human intervention study showed that 
daily consumption of coffee C21 (750 ml/day) for four weeks decreased spontaneous DNA strand 
breaks in habitual coffee drinkers after coffee withdrawal over the previous four weeks, but that no 
other human studies in which these results have been replicated were provided, and that no evidence 
was provided for a mechanism by which coffee (including coffee C21) could exert the claimed effect.  
The Panel concludes that a cause and effect relationship has not been established between the 
consumption of coffee C21, a coffee standardised by its content of caffeoylquinic acids, trigonelline 
and NMP, and a reduction of DNA damage by decreasing spontaneous DNA strand breaks. 
CONCLUSIONS 
On the basis of the data presented, the Panel concludes that:  
 The food, coffee C21, a coffee standardised by its content of caffeoylquinic acids, trigonelline 
and NMP, which is the subject of the health claim, is sufficiently characterised.  
 The claimed effect proposed by the applicant is ‘reduction of the amount of spontaneous 
DNA strand breaks in white blood cells’. The target population proposed by the applicant is 
the general population. A reduction of DNA damage by decreasing spontaneous DNA strand 
breaks is a beneficial physiological effect.  
 A cause and effect relationship has not been established between the consumption of coffee 
C21, a coffee standardised by its content of caffeoylquinic acids, trigonelline and NMP, and a 
reduction of DNA damage by decreasing spontaneous DNA strand breaks.  
DOCUMENTATION PROVIDED TO EFSA 
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ABBREVIATIONS 
ANCOVA analysis of covariance 
ARE   antioxidant response elements 
BMI  body mass index 
DNA  deoxyribonucleic acid 
EpRE  electrophile response element  
NMP  N-methylpyridinium 
Nrf2  nuclear-factor-E2-related factor 2 
TI %  tail intensity 
